Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yamada K et al. – This phase I, open–label study investigated the Toll–like receptor 9 agonist, PF–3512676, in combination with carboplatin and paclitaxel in Japanese patients with advanced, non–small–cell lung cancer (NSCLC). PF–3512676 as monotherapy and in combination with chemotherapy had an acceptable safety profile in Japanese patients with treatment–naive NSCLC.

Today in Clinical Pharmacology...keeping you current

Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/07/09

Usefulness of reagent strips for checking cure in spontaneous bacterial peritonitis after short-course treatment
Alimentary Pharmacology and Therapeutics, 12/07/09

Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease
Alimentary Pharmacology and Therapeutics, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address